乐胖代购免代理版

{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T18:40:41Z","timestamp":1732041641361},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,6,26]],"date-time":"2022-06-26T00:00:00Z","timestamp":1656201600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,26]],"date-time":"2022-06-26T00:00:00Z","timestamp":1656201600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","award":["CENTRO-01-0145-FEDER-029266","CENTRO-01-0145-FEDER-029266"]},{"name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","award":["CENTRO-01-0145-FEDER-029266","CENTRO-01-0145-FEDER-029266"]},{"name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","award":["CENTRO-01-0145-FEDER-029266","CENTRO-01-0145-FEDER-029266"]},{"name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","award":["CENTRO-01-0145-FEDER-029266","CENTRO-01-0145-FEDER-029266"]},{"name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","award":["CENTRO-01-0145-FEDER-029266","CENTRO-01-0145-FEDER-029266"]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cheminform"],"abstract":"Abstract<\/jats:title>Drug design is an important area of study for pharmaceutical businesses. However, low efficacy, off-target delivery, time consumption, and high cost are challenges and can create barriers that impact this process. Deep Learning models are emerging as a promising solution to perform de novo drug design, i.e., to generate drug-like molecules tailored to specific needs. However, stereochemistry was not explicitly considered in the generated molecules, which is inevitable in targeted-oriented molecules. This paper proposes a framework based on Feedback Generative Adversarial Network (GAN) that includes optimization strategy by incorporating Encoder\u2013Decoder, GAN, and Predictor deep models interconnected with a feedback loop. The Encoder\u2013Decoder converts the string notations of molecules into latent space vectors, effectively creating a new type of molecular representation. At the same time, the GAN can learn and replicate the training data distribution and, therefore, generate new compounds. The feedback loop is designed to incorporate and evaluate the generated molecules according to the multiobjective desired property at every epoch of training to ensure a steady shift of the generated distribution towards the space of the targeted properties. Moreover, to develop a more precise set of molecules, we also incorporate a multiobjective optimization selection technique based on a non-dominated sorting genetic algorithm. The results demonstrate that the proposed framework can generate realistic, novel molecules that span the chemical space. The proposed Encoder\u2013Decoder model correctly reconstructs 99% of the datasets, including stereochemical information. The model\u2019s ability to find uncharted regions of the chemical space was successfully shown by optimizing the unbiased GAN to generate molecules with a high binding affinity to the Kappa Opioid and Adenosine

$$A_ {2a}$$<\/jats:tex-math>\n \n A<\/mml:mi>\n \n 2<\/mml:mn>\n a<\/mml:mi>\n <\/mml:mrow>\n <\/mml:msub>\n <\/mml:math><\/jats:alternatives><\/jats:inline-formula> receptor. Furthermore, the generated compounds exhibit high internal and external diversity levels 0.88 and 0.94, respectively, and uniqueness.<\/jats:p>","DOI":"10.1186\/s13321-022-00623-6","type":"journal-article","created":{"date-parts":[[2022,6,26]],"date-time":"2022-06-26T11:02:41Z","timestamp":1656241361000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Designing optimized drug candidates with Generative Adversarial Network"],"prefix":"10.1186","volume":"14","author":[{"given":"Maryam","family":"Abbasi","sequence":"first","affiliation":[]},{"given":"Beatriz P.","family":"Santos","sequence":"additional","affiliation":[]},{"given":"Tiago C.","family":"Pereira","sequence":"additional","affiliation":[]},{"given":"Raul","family":"Sofia","sequence":"additional","affiliation":[]},{"given":"Nelson R. C.","family":"Monteiro","sequence":"additional","affiliation":[]},{"given":"Carlos J. V.","family":"Sim\u00f5es","sequence":"additional","affiliation":[]},{"given":"Rui M. M.","family":"Brito","sequence":"additional","affiliation":[]},{"given":"Bernardete","family":"Ribeiro","sequence":"additional","affiliation":[]},{"given":"Jos\u00e9 L.","family":"Oliveira","sequence":"additional","affiliation":[]},{"given":"Joel P.","family":"Arrais","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2022,6,26]]},"reference":[{"key":"623_CR1","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.jhealeco.2016.01.012","volume":"47","author":"JA DiMasi","year":"2016","unstructured":"DiMasi JA, Grabowski HG, Hansen RW (2016) Innovation in the pharmaceutical industry: new estimates of r&d costs. J Health Econ 47:20\u201333","journal-title":"J Health Econ"},{"issue":"1","key":"623_CR2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1177\/2472630320956931","volume":"26","author":"MBMA Rashid","year":"2021","unstructured":"Rashid MBMA (2021) Artificial intelligence effecting a paradigm shift in drug development. SLAS Technol 26(1):3\u201315","journal-title":"SLAS Technol"},{"issue":"10","key":"623_CR3","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.7150\/ijbs.24612","volume":"14","author":"H Xue","year":"2018","unstructured":"Xue H, Li J, Xie H, Wang Y (2018) Review of drug repositioning approaches and resources. Int J Biol Sci 14(10):1232","journal-title":"Int J Biol Sci"},{"issue":"8","key":"623_CR4","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1007\/s10822-013-9672-4","volume":"27","author":"PG Polishchuk","year":"2013","unstructured":"Polishchuk PG, Madzhidov TI, Varnek A (2013) Estimation of the size of drug-like chemical space based on gdb-17 data. J Comput Aided Mol Des 27(8):675\u2013679","journal-title":"J Comput Aided Mol Des"},{"issue":"6","key":"623_CR5","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1038\/nchem.2479","volume":"8","author":"T Rodrigues","year":"2016","unstructured":"Rodrigues T, Reker D, Schneider P, Schneider G (2016) Counting on natural products for drug design. Nat Chem 8(6):531","journal-title":"Nat Chem"},{"issue":"4","key":"623_CR6","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.3390\/ijms22041676","volume":"22","author":"VD Mouchlis","year":"2021","unstructured":"Mouchlis VD, Afantitis A, Serra A, Fratello M, Papadiamantis AG, Aidinis V, Lynch I, Greco D, Melagraki G (2021) Advances in de novo drug design: from conventional to machine learning methods. Int J Mol Sci 22(4):1676","journal-title":"Int J Mol Sci"},{"issue":"8","key":"623_CR7","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1038\/nrd1799","volume":"4","author":"G Schneider","year":"2005","unstructured":"Schneider G, Fechner U (2005) Computer-based de novo design of drug-like molecules. Nat Rev Drug Discov 4(8):649\u2013663","journal-title":"Nat Rev Drug Discov"},{"issue":"2","key":"623_CR8","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1021\/acscentsci.7b00572","volume":"4","author":"R G\u00f3mez-Bombarelli","year":"2018","unstructured":"G\u00f3mez-Bombarelli R, Wei JN, Duvenaud D, Hern\u00e1ndez-Lobato JM, S\u00e1nchez-Lengeling B, Sheberla D, Aguilera-Iparraguirre J, Hirzel TD, Adams RP, Aspuru-Guzik A (2018) Automatic chemical design using a data-driven continuous representation of molecules. ACS Cent Sci 4(2):268\u2013276","journal-title":"ACS Cent Sci"},{"issue":"1\u20132","key":"623_CR9","doi-asserted-by":"publisher","first-page":"1700111","DOI":"10.1002\/minf.201700111","volume":"37","author":"A Gupta","year":"2018","unstructured":"Gupta A, M\u00fcller AT, Huisman BJH, Fuchs JA, Schneider P, Schneider G (2018) Generative recurrent networks for de novo drug design. Mol Inform 37(1\u20132):1700111","journal-title":"Mol Inform"},{"issue":"1","key":"623_CR10","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1021\/acscentsci.7b00512","volume":"4","author":"MHS Segler","year":"2018","unstructured":"Segler MHS, Kogej T, Tyrchan C, Waller MP (2018) Generating focused molecule libraries for drug discovery with recurrent neural networks. ACS Cent Sci 4(1):120\u2013131","journal-title":"ACS Cent Sci"},{"issue":"3\u20134","key":"623_CR11","first-page":"229","volume":"8","author":"RJ Williams","year":"1992","unstructured":"Williams RJ (1992) Simple statistical gradient-following algorithms for connectionist reinforcement learning. Mach learn 8(3\u20134):229\u2013256","journal-title":"Mach learn"},{"key":"623_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s13321-017-0235-x","author":"M Olivecrona","year":"2017","unstructured":"Olivecrona M, Blaschke T, Engkvist O, Chen H (2017) Molecular de novo design through deep reinforcement learning. J Cheminform. https:\/\/doi.org\/10.1186\/s13321-017-0235-x","journal-title":"J Cheminform"},{"issue":"1","key":"623_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13321-019-0355-6","volume":"11","author":"X Liu","year":"2019","unstructured":"Liu X, Ye K, van Vlijmen HWT, IJzerman AP, Van Westen GJP, (2019) An exploration strategy improves the diversity of de novo ligands using deep reinforcement learning: a case for the adenosine a 2a receptor. J Cheminform 11(1):1\u201316","journal-title":"J Cheminform"},{"issue":"7","key":"623_CR14","doi-asserted-by":"publisher","first-page":"7885","DOI":"10.1126\/sciadv.aap7885","volume":"4","author":"M Popova","year":"2018","unstructured":"Popova M, Isayev O, Tropsha A (2018) Deep reinforcement learning for de novo drug design. Sci Adv 4(7):7885","journal-title":"Sci Adv"},{"issue":"1","key":"623_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13321-019-0328-9","volume":"11","author":"S Zheng","year":"2019","unstructured":"Zheng S, Yan X, Gu Q, Yang Y, Du Y, Lu Y, Xu J (2019) Qbmg: quasi-biogenic molecule generator with deep recurrent neural network. J Cheminform 11(1):1\u201312","journal-title":"J Cheminform"},{"key":"623_CR16","unstructured":"Guimaraes GL, Sanchez-Lengeling B, Outeiral C, Farias PLC, Aspuru-Guzik A (2017) Objective-reinforced generative adversarial networks (organ) for sequence generation models. arXiv preprint arXiv:1705.10843"},{"key":"623_CR17","doi-asserted-by":"crossref","unstructured":"Yu L, Zhang W, Wang J, Yu Y (2017) Seqgan: Sequence generative adversarial nets with policy gradient. In: Proceedings of the AAAI Conference on Artificial Intelligence, vol. 31","DOI":"10.1609\/aaai.v31i1.10804"},{"issue":"1\u20132","key":"623_CR18","doi-asserted-by":"publisher","first-page":"1700123","DOI":"10.1002\/minf.201700123","volume":"37","author":"T Blaschke","year":"2018","unstructured":"Blaschke T, Olivecrona M, Engkvist O, Bajorath J, Chen H (2018) Application of generative autoencoder in de novo molecular design. Mol Inform 37(1\u20132):1700123","journal-title":"Mol Inform"},{"key":"623_CR19","doi-asserted-by":"crossref","unstructured":"Gui J, Sun Z, Wen Y, Tao D, Ye J (2021) A review on generative adversarial networks: algorithms, theory, and applications. In: IEEE transactions on knowledge and data engineering","DOI":"10.1109\/TKDE.2021.3130191"},{"issue":"6","key":"623_CR20","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1021\/acs.jcim.7b00690","volume":"58","author":"E Putin","year":"2018","unstructured":"Putin E, Asadulaev A, Ivanenkov Y, Aladinskiy V, Sanchez-Lengeling B, Aspuru-Guzik A, Zhavoronkov A (2018) Reinforced adversarial neural computer for de novo molecular design. J Chem Inform Model 58(6):1194\u20131204","journal-title":"J Chem Inform Model"},{"issue":"1","key":"623_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13321-019-0397-9","volume":"11","author":"O Prykhodko","year":"2019","unstructured":"Prykhodko O, Johansson SV, Kotsias P, Ar\u00fas-Pous J, Bjerrum EJk, Engkvist O, Chen H, (2019) A de novo molecular generation method using latent vector based generative adversarial network. J Cheminform 11(1):1\u201313","journal-title":"J Cheminform"},{"issue":"6","key":"623_CR22","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1016\/j.drudis.2021.02.011","volume":"26","author":"J Xiong","year":"2021","unstructured":"Xiong J, Xiong Z, Chen K, Jiang H, Zheng M (2021) Graph neural networks for automated de novo drug design. Drug Discov Today 26(6):1382\u20131393","journal-title":"Drug Discov Today"},{"issue":"1","key":"623_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-020-79682-4","volume":"11","author":"D Grechishnikova","year":"2021","unstructured":"Grechishnikova D (2021) Transformer neural network for protein-specific de novo drug generation as a machine translation problem. Sci Rep 11(1):1\u201313","journal-title":"Sci Rep"},{"key":"623_CR24","doi-asserted-by":"crossref","unstructured":"Cho K, Van\u00a0Merri\u00ebnboer B, Gulcehre C, Bahdanau D, Bougares F, Schwenk H, Bengio Y (2014) Learning phrase representations using rnn encoder\u2013decoder for statistical machine translation. arXiv preprint arXiv:1406.1078","DOI":"10.3115\/v1\/D14-1179"},{"key":"623_CR25","unstructured":"Sutskever I, Vinyals O, Le QV (2014) Sequence to sequence learning with neural networks. arXiv preprint arXiv:1409.3215"},{"key":"623_CR26","unstructured":"Gulrajani I, Ahmed F, Arjovsky M, Dumoulin V, Courville AC (2017) Improved training of wasserstein gans. Advances in neural information processing systems. 30"},{"issue":"1","key":"623_CR27","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1093\/bioinformatics\/btab301","volume":"37","author":"T Pereira","year":"2021","unstructured":"Pereira T, Abbasi M, Oliveira JL, Ribeiro B, Arrais J (2021) Optimizing blood-brain barrier permeation through deep reinforcement learning for de novo drug design. Bioinformatics 37(1):84\u201392","journal-title":"Bioinformatics"},{"key":"623_CR28","unstructured":"Goodfellow IJ, Pouget-Abadie J, Mirza M, Xu B, Warde-Farley D, Ozair S, Courville A, Bengio Y (2014) Generative adversarial networks. arXiv preprint arXiv:1406.2661"},{"issue":"2","key":"623_CR29","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/s42256-019-0017-4","volume":"1","author":"A Gupta","year":"2019","unstructured":"Gupta A, Zou J (2019) Feedback GAN for DNA optimizes protein functions. Nat Mach Intell 1(2):105\u2013111","journal-title":"Nat Mach Intell"},{"issue":"20","key":"623_CR30","doi-asserted-by":"publisher","first-page":"3714","DOI":"10.1021\/jm000942e","volume":"43","author":"P Ertl","year":"2000","unstructured":"Ertl P, Rohde B, Selzer P (2000) Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties. J Med Chem 43(20):3714\u20133717","journal-title":"J Med Chem"},{"issue":"1","key":"623_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1758-2946-1-8","volume":"1","author":"P Ertl","year":"2009","unstructured":"Ertl P, Schuffenhauer A (2009) Estimation of synthetic accessibility score of drug-like molecules based on molecular complexity and fragment contributions. J Cheminform 1(1):1\u201311","journal-title":"J Cheminform"},{"issue":"1","key":"623_CR32","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1093\/nar\/gkr777","volume":"40","author":"A Gaulton","year":"2012","unstructured":"Gaulton A, Bellis LJ, Bento AP, Chambers J, Davies M, Hersey A, Light Y, McGlinchey S, Michalovich D, Al-Lazikani B et al (2012) Chembl: a large scale bioactivity database for drug discovery. Nucleic Acids Res 40(1):1100\u20131107","journal-title":"Nucleic Acids Res"},{"key":"623_CR33","doi-asserted-by":"publisher","first-page":"427","DOI":"10.3389\/fphar.2019.00427","volume":"10","author":"Z Wang","year":"2019","unstructured":"Wang Z, Kang W, You Y, Pang J, Ren H, Suo Z, Liu H, Zheng Y (2019) Usp7: novel drug target in cancer therapy. Front Pharmacol 10:427","journal-title":"Front Pharmacol"},{"issue":"1","key":"623_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1758-2946-4-22","volume":"4","author":"NM O\u2019Boyle","year":"2012","unstructured":"O\u2019Boyle NM (2012) Towards a universal smiles representation-a standard method to generate canonical smiles based on the inchi. J Cheminform 4(1):1\u201314","journal-title":"J Cheminform"},{"key":"623_CR35","unstructured":"Bahdanau D, Cho K, Bengio Y (2014) Neural machine translation by jointly learning to align and translate. arXiv preprint arXiv:1409.0473"},{"key":"623_CR36","unstructured":"Ioffe S, Szegedy C (2015) Batch normalization: Accelerating deep network training by reducing internal covariate shift. In: International conference on machine learning, pp. 448\u2013456. PMLR"},{"issue":"21","key":"623_CR37","doi-asserted-by":"publisher","first-page":"5092","DOI":"10.3390\/molecules25215092","volume":"25","author":"H Schmidhammer","year":"2020","unstructured":"Schmidhammer H, Erli F, Guerrieri E, Spetea M (2020) Development of diphenethylamines as selective kappa opioid receptor ligands and their pharmacological activities. Molecules 25(21):5092","journal-title":"Molecules"},{"key":"623_CR38","doi-asserted-by":"publisher","first-page":"170","DOI":"10.3389\/fpsyt.2014.00170","volume":"5","author":"L Lalanne","year":"2014","unstructured":"Lalanne L, Ayranci G, Kieffer BL, Lutz P-E (2014) The kappa opioid receptor: from addiction to depression, and back. Front Psychiatry 5:170","journal-title":"Front Psychiatry"},{"key":"623_CR39","doi-asserted-by":"publisher","first-page":"407","DOI":"10.3389\/fphar.2019.00407","volume":"10","author":"KL Mores","year":"2019","unstructured":"Mores KL, Cummins BR, Cassell RJ, Van Rijn RM (2019) A review of the therapeutic potential of recently developed g protein-biased kappa agonists. Front Pharmacol 10:407","journal-title":"Front Pharmacol"},{"key":"623_CR40","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.ejphar.2015.05.012","volume":"763","author":"Y Shang","year":"2015","unstructured":"Shang Y, Filizola M (2015) Opioid receptors: structural and mechanistic insights into pharmacology and signaling. Eur J Pharmacol 763:206\u2013213","journal-title":"Eur J Pharmacol"},{"key":"623_CR41","unstructured":"Pereira T, Abbasi M, Ribeiro B, Arrais JP (2020) End-to-end deep reinforcement learning for targeted drug generation. In: In ICCBB 2020: 2020 4th International conference on computational biology and bioinformatics"},{"key":"623_CR42","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3389\/frai.2019.00017","volume":"2","author":"SK Chakravarti","year":"2019","unstructured":"Chakravarti SK, Alla SRM (2019) Descriptor free qsar modeling using deep learning with long short-term memory neural networks. Front Artif Intelli 2:17","journal-title":"Front Artif Intelli"},{"key":"623_CR43","unstructured":"Landrum G et al (2006) RDKit: Open-source cheminformatics"},{"key":"623_CR44","first-page":"849","volume-title":"Proceedings the Sixth International Conference in Parallel Problem Solving from Nature - PPSN. VI Lecture Notes in Computer Science, volume 1917","author":"K Deb","year":"2000","unstructured":"Deb K, Agrawal S, Pratap A, Meyarivan T (2000) A fast elitist non-dominated sorting genetic algorithm for multi-objective optimization: NSGA-II. In: Schoenauer M, Deb K, Rudolph G, Yao X, Lutton E, Merelo JJ, Schwefel H-P (eds) Proceedings the Sixth International Conference in Parallel Problem Solving from Nature - PPSN. VI Lecture Notes in Computer Science, volume 1917. Springer, Cham, pp 849\u2013858"},{"issue":"3","key":"623_CR45","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1021\/acs.jcim.8b00839","volume":"59","author":"N Brown","year":"2019","unstructured":"Brown N, Fiscato M, Segler MH, Vaucher AC (2019) Guacamol: benchmarking models for de novo molecular design. J Chem inform Model 59(3):1096\u20131108","journal-title":"J Chem inform Model"},{"issue":"1","key":"623_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13321-015-0069-3","volume":"7","author":"D Bajusz","year":"2015","unstructured":"Bajusz D, R\u00e1cz A, H\u00e9berger K (2015) Why is tanimoto index an appropriate choice for fingerprint-based similarity calculations? J Cheminform 7(1):1\u201313","journal-title":"J Cheminform"}],"updated-by":[{"updated":{"date-parts":[[2022,8,11]],"date-time":"2022-08-11T00:00:00Z","timestamp":1660176000000},"DOI":"10.1186\/s13321-022-00631-6","type":"correction","label":"Correction"}],"container-title":["Journal of Cheminformatics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13321-022-00623-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13321-022-00623-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13321-022-00623-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,12]],"date-time":"2022-08-12T06:07:03Z","timestamp":1660284423000},"score":1,"resource":{"primary":{"URL":"https:\/\/jcheminf.biomedcentral.com\/articles\/10.1186\/s13321-022-00623-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,26]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["623"],"URL":"https:\/\/doi.org\/10.1186\/s13321-022-00623-6","relation":{},"ISSN":["1758-2946"],"issn-type":[{"value":"1758-2946","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,26]]},"assertion":[{"value":"1 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2022","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s13321-022-00631-6","URL":"https:\/\/doi.org\/10.1186\/s13321-022-00631-6","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"40"}}